Promising drug slows down advance of Parkinson's disease and improves symptoms
Treating Parkinson's disease patients with the experimental drug GM1 ganglioside improved symptoms and slowed their progression during a two and a half-year trial, Thomas Jefferson University researchers report in a new study ...
Parkinson's & Movement disorders
Nov 29, 2012 |
5 / 5 (2) |
0
|
Scientists identify potential drug target for inflammatory diseases including cancers
A*STAR scientists have identified the enzyme, telomerase, as a cause of chronic inflammation in human cancers. Chronic inflammation is now recognized as a key underlying cause for the development of many human cancers, autoimmune ...
Inflammatory disorders
Nov 21, 2012 |
not rated yet |
0
|
More work needed on models to predict risk of chronic kidney disease
Models used for predicting the likelihood of individuals developing chronic kidney disease and for predicting disease progression in people who already have the condition are useful tools but not yet robust enough to help ...
Diseases, Conditions, Syndromes
Nov 20, 2012 |
not rated yet |
0
GHSU researcher assesses driving capability in MS patients
A simple, accurate testing protocol to determine driving fitness in individuals with multiple sclerosis is the aim of a three-year study at Georgia Health Sciences University.
Diseases, Conditions, Syndromes
Nov 20, 2012 |
not rated yet |
0
Reconsidering cancer's bad guy
Researchers at the University of Copenhagen have found that a protein, known for causing cancer cells to spread around the body, is also one of the molecules that trigger repair processes in the brain. These ...
Medical research
Nov 16, 2012 |
4.3 / 5 (3) |
0
Parkinson's disease protein causes disease spread and neuron death in healthy animals
Understanding how any disease progresses is one of the first and most important steps towards finding treatments to stop it. This has been the case for such brain-degenerating conditions as Alzheimer's disease. ...
Parkinson's & Movement disorders
Nov 15, 2012 |
5 / 5 (6) |
1
|
Spread of human melanoma cells in mice correlates with clinical outcomes in patients
UT Southwestern Medical Center scientists led by Dr. Sean Morrison, director of the Children's Medical Center Research Institute at UT Southwestern, have developed an innovative model for predicting the progression of skin ...
Cancer
Nov 07, 2012 |
not rated yet |
0
|
Combination treatment may improve survival of breast cancer patients with brain metastases
Adding an angiogenesis inhibitor to treatment with a HER2-inhibiting drug could improve outcomes for patients with HER2-positive breast cancer who develop brain metastases. In their report published online in PNAS Plus, ...
Cancer
Nov 01, 2012 |
not rated yet |
0
Immune cells of the blood might replace dysfunctional brain cells
Blood-circulating immune cells can take over the essential immune surveillance of the brain, this is shown by scientists of the German Center for Neurodegenerative Diseases and the Hertie Institute for Clinical Brain Research ...
Medical research
Oct 22, 2012 |
not rated yet |
0
|
Some MS patients experience 'natural' improvements in disability
(Medical Xpress)—Multiple sclerosis (MS) patients sometimes experience "natural" improvements in disability at least over the short term, according to a new study led by researchers at the University of British Columbia ...
Neuroscience
Oct 18, 2012 |
3 / 5 (1) |
0
|
Active surveillance provides a viable alternative to surgery for small kidney masses
Active surveillance of small kidney masses is a safe and effective alternative to immediate surgery, with similar overall and cancer specific survival rates, according to a study published in the November issue of the urology ...
Surgery
Oct 17, 2012 |
not rated yet |
0
Diverse intestinal viruses may play a role in AIDS progression
In monkeys and humans with AIDS, damage to the gastrointestinal tract is common, contributing to activation of the immune system, progressive immune deficiency, and ultimately advanced AIDS. How this gastric damage occurs ...
HIV & AIDS
Oct 11, 2012 |
not rated yet |
0
|
Astrocytes as a novel target in Alzheimer's disease
Alzheimer's disease is a severe neurodegenerative disease that affects 45% of people over 85 years of age. The research teams of Prof. Jin-Moo Lee at Washington University in Saint Louis, USA, and Prof. Milos Pekny at Sahlgrenska ...
Alzheimer's disease & dementia
Oct 11, 2012 |
not rated yet |
0
Study gives clues to causes of motor neurone disease
(Medical Xpress)—Scientists at the University of Bath are one step further to understanding the role of one of the proteins that causes the neurodegenerative disorder, Amyotrophic Lateral Sclerosis (ALS), ...
Medical research
Oct 10, 2012 |
not rated yet |
0
|
Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer
The results of a new phase III trial show that crizotinib, a targeted therapy, is a more effective treatment than standard chemotherapy for patients with advanced, ALK-positive lung cancer, researchers said at the ESMO 2012 ...
Cancer
Sep 30, 2012 |
not rated yet |
0
